The Enterprise Value as of December 2025 (TTM) for Nuo Therapeutics, Inc. (AURX) is 108.26M

According to Nuo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 108.26M. This represents a change of 50.19% compared to the average of 72.08M of the last 4 quarters.

Nuo Therapeutics, Inc. (AURX) Historical Enterprise Value (quarterly & annually)

How has AURX Enterprise Value performed in the past?

The mean historical Enterprise Value of Nuo Therapeutics, Inc. over the last ten years is 23.29M. The current 108.26M Enterprise Value has changed 46.39% with respect to the historical average. Over the past ten years (40 quarters), AURX's Enterprise Value was at its highest in in the September 2022 quarter at 110.60M. The Enterprise Value was at its lowest in in the September 2016 quarter at -900719.40.

Nuo Therapeutics, Inc. (AURX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nuo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nuo Therapeutics, Inc. (AURX) Average Enterprise Value

How has AURX Enterprise Value performed in the past?

The current Enterprise Value of Nuo Therapeutics, Inc. (AURX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nuo Therapeutics, Inc. (AURX) Enterprise Value vs. Peers

How is AURX’s Enterprise Value compared to its peers?

Nuo Therapeutics, Inc.’s Enterprise Value is less than Kintor Pharmaceutical Limited (824.09M), less than Paradigm Biopharmaceuticals Limited (127.34M), greater than Poolbeg Pharma PLC (15.21M), less than Hofseth BioCare ASA (562.31M), greater than Satellos Bioscience Inc. (41.10M), less than VitaSpring Biomedical Co. Ltd. (207.39M), greater than Imugene Limited (81.08M), greater than Green Growth Brands Inc. (76.39M), less than AVITA Medical, Inc. (127.50M), less than Starpharma Holdings Limited (152.19M),

Build a custom stock screener for Nuo Therapeutics, Inc. (AURX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuo Therapeutics, Inc. (AURX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.